These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia. Torpy DJ, Papanicolaou DA, Lotsikas AJ, Wilder RL, Chrousos GP, Pillemer SR. Arthritis Rheum; 2000 Apr; 43(4):872-80. PubMed ID: 10765933 [Abstract] [Full Text] [Related]
23. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity. Ochedalski T, Subburaju S, Wynn PC, Aguilera G. J Neuroendocrinol; 2007 Mar; 19(3):189-97. PubMed ID: 17280592 [Abstract] [Full Text] [Related]
24. Acute alcohol administration stimulates the activity of hypothalamic neurons that express corticotropin-releasing factor and vasopressin. Rivier C, Lee S. Brain Res; 1996 Jul 08; 726(1-2):1-10. PubMed ID: 8836539 [Abstract] [Full Text] [Related]
27. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro. Calogero AE, Scaccianoce S, Burrello N, Nicolai R, Muscolo LA, Kling MA, Angelucci L, D'Agata R. J Neuroendocrinol; 1996 Aug 08; 8(8):579-85. PubMed ID: 8866244 [Abstract] [Full Text] [Related]
28. Evidence that the central noradrenergic and adrenergic pathways activate the hypothalamic-pituitary-adrenal axis in the sheep. Liu JP, Clarke IJ, Funder JW, Engler D. Endocrinology; 1991 Jul 08; 129(1):200-9. PubMed ID: 1647297 [Abstract] [Full Text] [Related]
31. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies. Kumari M, Cover PO, Poyser RH, Buckingham JC. Br J Pharmacol; 1997 Jun 08; 121(3):459-68. PubMed ID: 9179387 [Abstract] [Full Text] [Related]
32. Combined hypervolemia and hypoosmolality alter hypothalamic-pituitary-adrenal axis response to endotoxin stimulation. Dadoun F, Velut JG, Guillaume V, Sauze N, Orsoni JC, Gaillard RC, Oliver CC. Neuroendocrinology; 1999 May 08; 69(5):352-9. PubMed ID: 10343176 [Abstract] [Full Text] [Related]
35. Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Stenzel-Poore MP, Cameron VA, Vaughan J, Sawchenko PE, Vale W. Endocrinology; 1992 Jun 08; 130(6):3378-86. PubMed ID: 1597149 [Abstract] [Full Text] [Related]
36. Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress. Pasquali R, Anconetani B, Chattat R, Biscotti M, Spinucci G, Casimirri F, Vicennati V, Carcello A, Labate AM. Metabolism; 1996 Mar 08; 45(3):351-6. PubMed ID: 8606643 [Abstract] [Full Text] [Related]
37. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. Mastorakos G, Weber JS, Magiakou MA, Gunn H, Chrousos GP. J Clin Endocrinol Metab; 1994 Oct 08; 79(4):934-9. PubMed ID: 7962300 [Abstract] [Full Text] [Related]
38. Age-related alterations of hypothalamic-pituitary-adrenal axis function in male Fischer 344 rats. Hauger RL, Thrivikraman KV, Plotsky PM. Endocrinology; 1994 Mar 08; 134(3):1528-36. PubMed ID: 8119195 [Abstract] [Full Text] [Related]